BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26035688)

  • 1. The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability.
    Wang J; Bi M; Liu H; Song N; Xie J
    Sci Rep; 2015 Jun; 5():10729. PubMed ID: 26035688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease in mice.
    Liu H; Wu H; Zhu N; Xu Z; Wang Y; Qu Y; Wang J
    J Neurochem; 2020 Feb; 152(3):397-415. PubMed ID: 31442326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apo- and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways.
    Jiang R; Lönnerdal B
    Int J Biochem Cell Biol; 2012 Jan; 44(1):91-100. PubMed ID: 22009034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
    Wang J; Song N; Jiang H; Wang J; Xie J
    Biochim Biophys Acta; 2013 May; 1832(5):618-25. PubMed ID: 23376588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells.
    Jiang R; Lopez V; Kelleher SL; Lönnerdal B
    J Cell Physiol; 2011 Nov; 226(11):3022-31. PubMed ID: 21935933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice.
    Xu SF; Zhang YH; Wang S; Pang ZQ; Fan YG; Li JY; Wang ZY; Guo C
    Redox Biol; 2019 Feb; 21():101090. PubMed ID: 30593976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.
    Delgado M; Ganea D
    FASEB J; 2003 May; 17(8):944-6. PubMed ID: 12626429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
    Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
    FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.
    Ren Z; Yang N; Ji C; Zheng J; Wang T; Liu Y; Zuo P
    Neuropharmacology; 2015 Jun; 93():209-18. PubMed ID: 25680233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life.
    Liao Y; Jiang R; Lönnerdal B
    Biochem Cell Biol; 2012 Jun; 90(3):476-84. PubMed ID: 22332905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells.
    Liu L; Xu H; Jiang H; Wang J; Song N; Xie J
    Exp Neurol; 2010 Mar; 222(1):25-9. PubMed ID: 19931250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.
    Liu B; Du L; Hong JS
    J Pharmacol Exp Ther; 2000 May; 293(2):607-17. PubMed ID: 10773035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.
    Borrajo A; Rodriguez-Perez AI; Villar-Cheda B; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Oct; 85():1-8. PubMed ID: 24878243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease.
    Xu Q; Kanthasamy AG; Reddy MB
    Toxicology; 2008 Mar; 245(1-2):101-8. PubMed ID: 18255213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin receptor mediates apo- but not holo-lactoferrin internalization via clathrin-mediated endocytosis in trophoblasts.
    Lopez V; Kelleher SL; Lonnerdal B
    Biochem J; 2008 Apr; 411(2):271-8. PubMed ID: 18171326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of lactoferrin in the iron metabolism. Part II. Antimicrobial and antiinflammatory effect of lactoferrin by chelation of iron].
    Artym J
    Postepy Hig Med Dosw (Online); 2010 Nov; 64():604-16. PubMed ID: 21160095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.
    Zhang S; Wang J; Song N; Xie J; Jiang H
    Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins.
    Choi WS; Canzoniero LM; Sensi SL; O'Malley KL; Gwag BJ; Sohn S; Kim JE; Oh TH; Lee EB; Oh YJ
    Exp Neurol; 1999 Sep; 159(1):274-82. PubMed ID: 10486196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.